News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
182,361 Results
Type
Article (8435)
Company Profile (28)
Press Release (173898)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (54029)
Career Advice (305)
Deals (9758)
Drug Delivery (10)
Drug Development (21414)
Employer Resources (14)
FDA (5105)
Job Trends (4502)
News (92984)
Policy (9972)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (1)
2024 Genetown Digital (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
Academia (839)
Academic (1)
Accelerated approval (1)
Adcomms (1)
Allergies (19)
Alliances (14767)
ALS (24)
Alzheimer's disease (366)
Antibody-drug conjugate (ADC) (23)
Approvals (5171)
Artificial intelligence (47)
Autoimmune disease (3)
Automation (10)
Bankruptcy (83)
Best Places to Work (3628)
BIOSECURE Act (1)
Biosimilars (13)
Biotechnology (23)
Bladder cancer (25)
Brain cancer (9)
Breast cancer (104)
Cancer (762)
Cardiovascular disease (48)
Career advice (275)
Career pathing (4)
CAR-T (32)
Cell therapy (83)
Cervical cancer (10)
Clinical research (17402)
Collaboration (245)
Compensation (35)
Complete response letters (5)
COVID-19 (900)
CRISPR (7)
C-suite (44)
Cystic fibrosis (25)
Data (719)
Depression (7)
Diabetes (63)
Diagnostics (3682)
Digital health (6)
Diversity, equity & inclusion (1)
Drug discovery (28)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (21453)
Editorial (2)
Employer branding (4)
Employer resources (11)
Events (22343)
Executive appointments (189)
FDA (5486)
Featured Employer (5)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (145)
Gene editing (19)
Generative AI (4)
Gene therapy (63)
GLP-1 (135)
Government (1675)
Grass and pollen (3)
Guidances (19)
Healthcare (4339)
Huntington's disease (2)
IgA nephropathy (3)
Immunology and inflammation (11)
Indications (10)
Infectious disease (951)
Inflammatory bowel disease (30)
Influenza (23)
Intellectual property (39)
Interviews (37)
IPO (4129)
Job creations (1034)
Job search strategy (257)
Kidney cancer (5)
Labor market (3)
Layoffs (46)
Leadership (2)
Legal (1847)
Liver cancer (15)
Lung cancer (126)
Lymphoma (40)
Machine learning (2)
Management (4)
Manufacturing (83)
MASH (25)
Medical device (2887)
Medtech (2887)
Mergers & acquisitions (5823)
Metabolic disorders (140)
Multiple sclerosis (23)
NASH (6)
Neurodegenerative disease (19)
Neuropsychiatric disorders (2)
Neuroscience (475)
NextGen: Class of 2025 (1596)
Non-profit (850)
Northern California (754)
Now hiring (11)
Obesity (60)
Opinion (25)
Ovarian cancer (20)
Pain (22)
Pancreatic cancer (38)
Parkinson's disease (30)
Partnered (5)
Patents (63)
Patient recruitment (20)
Peanut (10)
People (14618)
Pharmaceutical (7)
Phase I (5471)
Phase II (7408)
Phase III (5905)
Pipeline (402)
Policy (9)
Postmarket research (681)
Preclinical (2473)
Press Release (19)
Prostate cancer (39)
Psychedelics (4)
Radiopharmaceuticals (56)
Rare diseases (80)
Real estate (2429)
Recruiting (5)
Regulatory (7113)
Reports (10)
Research institute (751)
Resumes & cover letters (38)
RSV (10)
Schizophrenia (4)
Series A (20)
Series B (13)
Sickle cell disease (5)
Southern California (725)
Spinal muscular atrophy (47)
Sponsored (7)
Startups (806)
State (1)
Stomach cancer (2)
Supply chain (17)
Tariffs (1)
The Weekly (2)
United States (6698)
Vaccines (132)
Venture capitalists (4)
Weight loss (18)
Women's health (4)
Date
Today (36)
Last 7 days (221)
Last 30 days (666)
Last 365 days (8997)
2025 (2751)
2024 (9887)
2023 (11407)
2022 (14933)
2021 (16056)
2020 (15573)
2019 (11356)
2018 (8558)
2017 (9049)
2016 (8489)
2015 (10272)
2014 (7733)
2013 (6412)
2012 (6984)
2011 (7446)
2010 (6620)
Location
Africa (173)
Alabama (15)
Alaska (1)
Arizona (54)
Arkansas (6)
Asia (11930)
Australia (1504)
California (1802)
Canada (523)
China (105)
Colorado (109)
Connecticut (93)
Delaware (45)
Europe (19402)
Florida (376)
Georgia (22)
Idaho (14)
Illinois (96)
India (4)
Indiana (73)
Iowa (2)
Japan (39)
Kansas (22)
Kentucky (7)
Louisiana (1)
Maine (48)
Maryland (432)
Massachusetts (990)
Michigan (67)
Minnesota (65)
Missouri (42)
Montana (16)
Nebraska (4)
Nevada (13)
New Hampshire (7)
New Jersey (614)
New Mexico (8)
New York (550)
North Carolina (213)
North Dakota (1)
Northern California (754)
Ohio (54)
Oklahoma (4)
Oregon (4)
Pennsylvania (356)
Puerto Rico (6)
Rhode Island (13)
South America (258)
South Carolina (7)
Southern California (725)
Tennessee (25)
Texas (345)
Utah (79)
Virginia (16)
Washington D.C. (19)
Washington State (176)
Wisconsin (12)
182,361 Results for "cold spring harbor laboratory".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
August 30, 2024
·
6 min read
Pharm Country
Cold Spring Harbor Laboratory and Deerfield Management Launch Harbor Discoveries to Advance New Therapeutics
Cold Spring Harbor Laboratory and healthcare investment firm, Deerfield Management, announced a research and development collaboration to help bring next-generation therapeutics to market.
January 5, 2023
·
2 min read
Pharm Country
Cold Spring Harbor Laboratory receives new funding for free biomedical research platforms
Cold Spring Harbor Laboratory announced that preprint servers bioRxiv and medRxiv have received renewed funding from the Chan Zuckerberg Initiative.
November 8, 2022
·
3 min read
Biotech Bay
Vittorio Sebastiano, Head of Turn Biotechnologies Research, to Present at Prestigious Cold Spring Harbor Laboratories
Turn Biotechnologies Co-founder and Head of Research Vittorio Sebastiano today will present at the Mechanisms of Aging Meeting taking place at Cold Spring Harbor Laboratories in New York.
September 30, 2022
·
1 min read
Business
Mark Claster elected Cold Spring Harbor Laboratory Trustee
On June 9, 2022, the Cold Spring Harbor Laboratory Board of Trustees elected Mark L. Claster to the private, not-for-profit institution’s governing body.
June 17, 2022
·
2 min read
Business
Elizabeth Cogan Fascitelli elected a Cold Spring Harbor Laboratory trustee
Cold Spring Harbor Laboratory announces the election of businesswoman and philanthropist Elizabeth Cogan Fascitelli to the private, not-for-profit institution’s board of trustees.
November 16, 2021
·
1 min read
Pharm Country
A link between breast changes and … UTIs?
Women’s health is often talked about in terms of major, life-altering events like pregnancy and menopause. A new study from Cold Spring Harbor Laboratory underscores the importance of considering everyday occurrences’ impact on women’s well-being.
May 2, 2024
·
2 min read
Biotech Bay
Metagenomi to Present at the Cold Spring Harbor Laboratory’s Genome Engineering: CRISPR Frontiers Conference
Metagenomi to Present at the Cold Spring Harbor Laboratory ’s Genome Engineering: CRISPR Frontiers Conference
August 16, 2021
·
2 min read
Kraig Biocraft Laboratories Prepares to Accelerate Production Launch following Spring Trials Success
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), announces today that it has completed its analysis of its spring spider silk production trials
May 20, 2024
·
3 min read
BioMidwest
Kraig Biocraft Laboratories Spring Spider Silk Production Trials Exceed Expectations
Kraig Biocraft Laboratories, Inc., announces that the spring production trials of the Company’s new BAM-1 hybrid parental strains have concluded, exceeding all expectations for scale, performance and robustness.
May 9, 2024
·
4 min read
1 of 18,237
Next
